Tulosta

Vitamiinit, hivenaineet ja rohdoskasvit sekä homeopaattiset valmisteet

Lisätietoa aiheesta
27.8.2008
Erkki Säkö

Kirjallisuutta

  1. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466-70 «PMID: 9484373»PubMed
  2. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994;14:328-9 «PMID: 7828189»PubMed
  3. Sandor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine withy beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 2000;40:30-5
  4. Boehnke C, Reuter U, Flach U ym. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004;11:475-7 «PMID: 15257686»PubMed
  5. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium and feverfew for migraine prophylaxis: a randomized trial. Headache 2004;44:885-90
  6. van der Kuy PH, Merkus FW, Lohman JJ ym. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia 2002;22:513-9 «PMID: 12230592»PubMed
  7. Sándor PS, Di Clemente L, Coppola G ym. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64:713-5 «PMID: 15728298»PubMed
  8. Hershey AD, Powers SW, Vockell AL ym. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47:73-80 «PMID: 17355497»PubMed
  9. Rozen TD, Oshinsky ML, Gebeline CA ym. Open label trial of coenzyme Q 10 as a migraine preventive. Cephalalgia 2002;22:137-41
  10. Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63 «PMID: 8792038»PubMed
  11. Taubert K. [Magnesium in migraine. Results of a multicenter pilot study]. Fortschr Med 1994;112:328-30 «PMID: 7959501»PubMed
  12. Wang F, Van Den Eeden SK, Ackerson LM ym. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003;43:601-10 «PMID: 12786918»PubMed
  13. Pfaffenrath V, Wessely P, Meyer C ym. Magnesium in the prophylaxis of migraine - a double- blind placebo-controlled study. Cephalalgia 1996;16:436-40
  14. Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004;51:89-97 «PMID: 14752215»PubMed
  15. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000;38:430-5 «PMID: 11020030»PubMed
  16. Lipton RB, Göbel H, Einhäupl KM ym. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004;63:2240-4 «PMID: 15623680»PubMed
  17. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d feverfew CO2- extract (Mig-99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled Study. Cephalalgia 2005;25:1031-41
  18. Pfaffenrath V, Diener HC, Fischer M ym. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002;22:523-32 «PMID: 12230594»PubMed
  19. Straumsheim P, Borchgrevink C, Mowinkel P, Kierulf H, Hafslund O. Homeopathic treatment oh migraine: a double blind, placebo controlled trial of 68 patients. Br Homeopath J 2000;89:4-7
  20. Whitmarsh TE, Coleston-Shields DM, Steiner TJ. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 1997;17:600-4 «PMID: 9251877»PubMed
  21. Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med 2003;138:393-9 «PMID: 12614092»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Migreeni
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko